38th Annual Symposium on Nonhuman Primate Models for AIDS
第38届非人类灵长类艾滋病模型年度研讨会
基本信息
- 批准号:10012735
- 负责人:
- 金额:$ 7.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-01 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:AIDS VaccinesAIDS preventionAIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAnti-HIV AgentsApplications GrantsArtsAwardBasic ScienceBudgetsCRISPR/Cas technologyClinicClinicalCollaborationsCommittee MembersDataDevelopmentDiseaseEmerging TechnologiesEnsureEnvironmentEquilibriumExperimental DesignsFeesFosteringFundingFutureGenderGenesGrantHIVHIV InfectionsHIV Vaccine Trials NetworkHIV vaccineHumanImmunologic Deficiency SyndromesIndividualInfectionInfection preventionInstitutesInternationalInterventionJournalsKnowledgeLightLinkLondonMedicalMedicineMentorsMinority ParticipationModelingMuseumsOralOregonParticipantPathogenesisPatientsPersonsPreventive vaccinePrimatesProcessPublishingRelapseRequest for ApplicationsResearchResearch PersonnelSIVScientistStem cell transplantTechniquesTechnologyTeleconferencesTestingTranslatingTranslationsTravelUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesVaccine DesignVaccinesViral PathogenesisVirus DiseasesWritinganalogantiretroviral therapybaseclinical applicationcosthigh risklecturesmeetingsmembermodel developmentnewsnonhuman primatenovelnovel therapeuticsoriginalityposterspreventprofessorprogramssuccesssymposiumtherapy designtherapy development
项目摘要
PROJECT SUMMARY
With this R13 application we request funding to support, in part, the costs for planning, organizing, publicizing,
and hosting the 38th Annual Symposium on Nonhuman Primate Models for AIDS. This symposium will be
hosted by the Oregon National Primate Research Center (ONPRC). It will be held at “The Nines” hotel located
in downtown Portland, Oregon, September 29 - October 2, 2020. Lodging will be offered at the same venue. In
addition to the funds requested in this R13 proposal, support will come from registration fees paid by meeting
participants and contributions from corporate sponsors. The overall format of the conference will begin with
registration and an evening reception on September 29, which will be followed by a keynote address given by
Dr. Sharon Lewin, Director of the Doherty Institute and Professor of Medicine, University of Melbourne. There
will be two and a half days of scientific presentations driven by both invited speakers and accepted oral
abstracts. A poster session will occur on the evening of September 30, and there will be a banquet, tentatively
planned for The Portland Art Museum on October 1. A major emphasis for this meeting will be on emerging
technologies that can advance research in NHP models of AIDS. Based on this theme, session topics and
speakers will be invited to highlight new and cutting-edge technologies in their respective fields. Each session
will open with a 25-minute talk by an invited Chair. Remaining session talks will be given by individuals whose
abstracts were accepted for oral presentations based on the quality and originality of the submission. There will
be an evening poster session for meritorious abstracts that cannot be accommodated in the oral sessions. As
is customary for this symposium, all poster and oral abstracts will be published in the Journal of Medical
Primatology. ONPRC will also be hosting a pre-symposium meeting for early stage investigators (ESI) on
September 29 in conjunction with a Translational ESI conference sponsored by the HIV Vaccine Trials Network
(HVTN) to be held September 28-29 in Portland, Oregon. This meeting will be open to the attendees of a
linked ESI Conference sponsored by the HVTN. The ESI attendees and mentors will develop a program
focused on networking, grant writing, budgeting and a Q&A with NIH Program Officers. In general, the main
objective of the annual symposium is to help disseminate the latest research findings in NHP models of AIDS,
while also fostering an environment that will facilitate discussion and exchange of ideas between basic
scientists and clinicians, as well as between early stage and established investigators. We believe that bringing
together researchers from a wide variety of different backgrounds will generate future collaborations. In all, we
hope that the 38th Annual Nonhuman Primate Models for AIDS Symposium will help identify the most effective
use of NHP models to better design interventions to prevent or eradicate HIV infection or to maintain long term
control of HIV replication in the absence of antiretroviral therapy.
项目摘要
通过此R13申请,我们要求资金支持计划,组织,发布,
并举办第38届艾滋病非人类灵长类动物模型的年度研讨会。这个研讨会将是
由俄勒冈州国家灵长类动物研究中心(ONPRC)主持。它将在位于“ Nines”酒店举行
9月29日至2020年10月29日,在俄勒冈州波特兰市中心。将在同一地点提供住宿。在
除本R13提案中要求的资金外,支持将来自会议支付的注册费
公司赞助商的参与者和贡献。会议的整体格式将以
9月29日的注册和均匀的招待会,随后将进行主题演讲
Doherty Institute主任兼墨尔本大学医学教授Sharon Lewin博士。那里
由受邀演讲者和接受口头的两天半的科学演讲进行
摘要。海报会议将于9月30日晚上举行,并将举行宴会
计划于10月1日在波特兰美术馆举行。这次会议的重点将是新兴
可以推进NHP艾滋病模型的技术。基于此主题,会话主题和
演讲者将被邀请在各自领域突出新的和尖端的技术。每个会话
将由受邀椅子进行25分钟的演讲。剩下的会议会话将由个人进行
根据提交的质量和独创性,接受了口头演讲的摘要。会在那里
成为在口头会议中无法容纳的有功摘要的晚间海报会议。作为
是本次研讨会的习惯,所有海报和口头摘要都将在《医学杂志》中发表
灵长类动物学。 ONPRC还将在早期调查人员(ESI)举行一次预选会议上
9月29日与HIV疫苗试验网络赞助的翻译ESI会议一起
(HVTN)将于9月28日至29日在俄勒冈州波特兰举行。这次会议将向与会者开放
链接的ESI会议由HVTN赞助。 ESI参与者和导师将制定一个计划
专注于与NIH计划官员的网络,赠款写作,预算和问答。通常,主要
年度研讨会的目的是帮助传播NHP艾滋病模型中的最新研究结果,
同时还促进了一个环境,该环境将促进基本之间的讨论和交流
科学家和临床医生以及早期和成熟的研究人员之间。我们相信带来
来自各种不同背景的研究人员将共同产生未来的合作。总的来说,我们
希望第38届艾滋病研讨会的年度非人类灵长类动物模型将有助于确定最有效的
使用NHP模型来更好地设计干预措施,以预防或放射性艾滋病毒感染或保持长期
在没有抗逆转录病毒疗法的情况下控制HIV复制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nancy L Haigwood其他文献
Nancy L Haigwood的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nancy L Haigwood', 18)}}的其他基金
PROBING the DYNAMICS of INFANT IMMUNITY to LIMIT HIV PERSISTENCE
探索婴儿免疫力的动态以限制艾滋病毒的持续存在
- 批准号:
9977916 - 财政年份:2017
- 资助金额:
$ 7.5万 - 项目类别:
PROBING the DYNAMICS of INFANT IMMUNITY to LIMIT HIV PERSISTENCE
探索婴儿免疫力的动态以限制艾滋病毒的持续存在
- 批准号:
10203803 - 财政年份:2017
- 资助金额:
$ 7.5万 - 项目类别:
PROBING the DYNAMICS of INFANT IMMUNITY to LIMIT HIV PERSISTENCE
探索婴儿免疫力的动态以限制艾滋病毒的持续存在
- 批准号:
9538578 - 财政年份:2017
- 资助金额:
$ 7.5万 - 项目类别:
Technological and Physical Enhancements for Primate Behavioral Testing Suites
灵长类动物行为测试套件的技术和物理增强
- 批准号:
8902409 - 财政年份:2015
- 资助金额:
$ 7.5万 - 项目类别:
Reducing Latent Viral Reservoirs in Infant Macaques
减少幼年猕猴的潜在病毒库
- 批准号:
10155511 - 财政年份:2014
- 资助金额:
$ 7.5万 - 项目类别:
Reducing Latent Viral Reservoirs in Infant Macaques
减少幼年猕猴的潜在病毒库
- 批准号:
10671515 - 财政年份:2014
- 资助金额:
$ 7.5万 - 项目类别:
Reducing Latent Viral Reservoirs in Infant Macaques
减少幼年猕猴的潜在病毒库
- 批准号:
10441140 - 财政年份:2014
- 资助金额:
$ 7.5万 - 项目类别:
Reducing Latent Viral Reservoirs in Infant Macaques
减少幼年猕猴的潜在病毒库
- 批准号:
8901254 - 财政年份:2014
- 资助金额:
$ 7.5万 - 项目类别:
Reducing Latent Viral Reservoirs in Infant Macaques
减少幼年猕猴的潜在病毒库
- 批准号:
9283606 - 财政年份:2014
- 资助金额:
$ 7.5万 - 项目类别:
Reducing Latent Viral Reservoirs in Infant Macaques
减少幼年猕猴的潜在病毒库
- 批准号:
8728687 - 财政年份:2014
- 资助金额:
$ 7.5万 - 项目类别:
相似国自然基金
去医学化综合性艾滋病暴露前预防决策支持系统及优化
- 批准号:72364039
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
新策略下我国艾滋病预防干预措施效果评估动态模型的构建和应用
- 批准号:81803334
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于系统动力学的预防艾滋病经家庭内传播研究
- 批准号:71774150
- 批准年份:2017
- 资助金额:48.0 万元
- 项目类别:面上项目
基于社会心理-行为协同效应的男男性行为者预防艾滋病干预措施及策略研究
- 批准号:71603166
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
基于创新扩散理论的广西农村校外青少年预防艾滋病互联网+健康教育干预研究
- 批准号:71663013
- 批准年份:2016
- 资助金额:30.0 万元
- 项目类别:地区科学基金项目
相似海外基金
CoVPN 3008 A Phase 3, Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
CoVPN 3008 COVID-19 mRNA 疫苗在 SARS-CoV-2 变异关注地区的 3 期、多中心、随机、功效研究
- 批准号:
10493538 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block rebound
项目 3 - 潜在 HIV-1 储存库的动态:高分辨率抗原图谱和阻止反弹的策略
- 批准号:
10506669 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Immunologic and Virologic Basis of RhCMV/SIV Vaccine-Induced Replication Arrest Efficacy
RhCMV/SIV 疫苗诱导复制抑制功效的免疫学和病毒学基础
- 批准号:
10619297 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
The 24th International AIDS Conference (AIDS 2022), 29 July-2 August 2022, Montreal, Canada and virtually
第 24 届国际艾滋病大会 (AIDS 2022),2022 年 7 月 29 日至 8 月 2 日,加拿大蒙特利尔
- 批准号:
10481133 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别: